Browsing by Author "Liu, Bing"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- Causal Gene Network Inference from Genetical Genomics Experiments via Structural Equation ModelingLiu, Bing (Virginia Tech, 2006-09-11)The goal of this research is to construct causal gene networks for genetical genomics experiments using expression Quantitative Trait Loci (eQTL) mapping and Structural Equation Modeling (SEM). Unlike Bayesian Networks, this approach is able to construct cyclic networks, while cyclic relationships are expected to be common in gene networks. Reconstruction of gene networks provides important knowledge about the molecular basis of complex human diseases and generally about living systems. In genetical genomics, a segregating population is expression profiled and DNA marker genotyped. An Encompassing Directed Network (EDN) of causal regulatory relationships among genes can be constructed with eQTL mapping and selection of candidate causal regulators. Several eQTL mapping approaches and local structural models were evaluated in their ability to construct an EDN. The edges in an EDN correspond to either direct or indirect causal relationships, and the EDN is likely to contain cycles or feedback loops. We implemented SEM with genetics algorithms to produce sub-models of the EDN containing fewer edges and being well supported by the data. The EDN construction and sparsification methods were tested on a yeast genetical genomics data set, as well as the simulated data. For the simulated networks, the SEM approach has an average detection power of around ninety percent, and an average false discovery rate of around ten percent.
- Identifying False Human Papillomavirus (HPV) Vaccine Information and Corresponding Risk Perceptions From Twitter: Advanced Predictive ModelsTomaszewski, Tre; Morales, Alex; Lourentzou, Ismini; Caskey, Rachel; Liu, Bing; Schwartz, Alan; Chin, Jessie (2021-09-09)Background: The vaccination uptake rates of the human papillomavirus (HPV) vaccine remain low despite the fact that the effectiveness of HPV vaccines has been established for more than a decade. Vaccine hesitancy is in part due to false information about HPV vaccines on social media. Combating false HPV vaccine information is a reasonable step to addressing vaccine hesitancy. Objective: Given the substantial harm of false HPV vaccine information, there is an urgent need to identify false social media messages before it goes viral. The goal of the study is to develop a systematic and generalizable approach to identifying false HPV vaccine information on social media. Methods: This study used machine learning and natural language processing to develop a series of classification models and causality mining methods to identify and examine true and false HPV vaccine-related information on Twitter. Results: We found that the convolutional neural network model outperformed all other models in identifying tweets containing false HPV vaccine-related information (F score=91.95). We also developed completely unsupervised causality mining models to identify HPV vaccine candidate effects for capturing risk perceptions of HPV vaccines. Furthermore, we found that false information contained mostly loss-framed messages focusing on the potential risk of vaccines covering a variety of topics using more diverse vocabulary, while true information contained both gain- and loss-framed messages focusing on the effectiveness of vaccines covering fewer topics using relatively limited vocabulary. Conclusions: Our research demonstrated the feasibility and effectiveness of using predictive models to identify false HPV vaccine information and its risk perceptions on social media.
- Predicting patients with septic shock and sepsis through analyzing whole-blood expression of NK cell-related hub genes using an advanced machine learning frameworkDu, Chao; Tan, Stephanie C.; Bu, Heng-Fu; Subramanian, Saravanan; Geng, Hua; Wang, Xiao; Xie, Hehuang; Wu, Xiaowei; Zhou, Tingfa; Liu, Ruijin; Xu, Zhen; Liu, Bing; Tan, Xiao-Di (Frontiers, 2024-11-28)Background: Sepsis is a life-threatening condition that causes millions of deaths globally each year. The need for biomarkers to predict the progression of sepsis to septic shock remains critical, with rapid, reliable methods still lacking. Transcriptomics data has recently emerged as a valuable resource for disease phenotyping and endotyping, making it a promising tool for predicting disease stages. Therefore, we aimed to establish an advanced machine learning framework to predict sepsis and septic shock using transcriptomics datasets with rapid turnaround methods. Methods: We retrieved four NCBI GEO transcriptomics datasets previously generated from peripheral blood samples of healthy individuals and patients with sepsis and septic shock. The datasets were processed for bioinformatic analysis and supplemented with a series of bench experiments, leading to the identification of a hub gene panel relevant to sepsis and septic shock. The hub gene panel was used to establish a novel prediction model to distinguish sepsis from septic shock through a multistage machine learning pipeline, incorporating linear discriminant analysis, risk score analysis, and ensemble method combined with Least Absolute Shrinkage and Selection Operator analysis. Finally, we validated the prediction model with the hub gene dataset generated by RT-qPCR using peripheral blood samples from newly recruited patients. Results: Our analysis led to identify six hub genes (GZMB, PRF1, KLRD1, SH2D1A, LCK, and CD247) which are related to NK cell cytotoxicity and septic shock, collectively termed 6-HubGss. Using this panel, we created SepxFindeR, a machine learning model that demonstrated high accuracy in predicting sepsis and septic shock and distinguishing septic shock from sepsis in a cross-database context. Remarkably, the SepxFindeR model proved compatible with RT-qPCR datasets based on the 6-HubGss panel, facilitating the identification of newly recruited patients with sepsis and septic shock. Conclusions: Our bioinformatic approach led to the discovery of the 6-HubGss biomarker panel and the development of the SepxFindeR machine learning model, enabling accurate prediction of septic shock and distinction from sepsis with rapid processing capabilities.